genetic testing
-
Color Genomics goes beyond cancer with a test for heart health
Cancer and heart disease are the two leading causes of death in the United States. So far, Color Genomics has been focused on testing for mutations leading to a higher risk of certain cancers. But, today the four-year-old company is introducing a new category of genetic testing for cardiovascular health. The new Color Hereditary High Cholesterol Test will tell you if you have a genetic… Read More
-
Genoox raises $6M to make genetic data analysis more accessible for clinics
Genoox, a startup that wants to make it easier for medical professionals to use genomic data in patient care, has raised $6 million in funding. The capital includes a seed round from Inimiti Capital Partners and a Series A round led by Glilot Capital Partners. Read More
-
23andMe is finally allowed to tell you if you have the genes for Parkinson’s
The Food and Drug Administration finally gave 23andMe a long sought-after green light today to sell to consumers genetic tests and their accompanying health risk reports for up to 10 diseases, including late-onset Alzheimer’s and Parkinson’s. Read More
-
23andMe’s Anne Wojcicki has a plan to include better genetic data from people of color
One of the first consumer genetic testing companies, 23andMe says it aims to be at the forefront in gathering genetically diverse data throughout the world. The company just launched a standalone $99 ancestry service today as a way to offer those interested in their genetic lineage the ability to trace ancestors and relatives just by spitting into a tube. Ancestral DNA is something founder… Read More
-
Citizen scientists, you can now DIY your own DNA analysis with Bento Lab
Want to know if you have the “athlete gene” or if you’re actually related to the weirdos who claim you as a family member? Get your collection tubes ready, citizen scientists, Bento Lab’s DIY DNA analysis kit is here and ready for the in-home lab. Normally you’d order a kit somewhere like 23andMe, spit in a tube and mail it off for results in six to eight weeks. Read More
-
FDA Clears 23andMe For Health and Carrier Status Testing
Things are looking up for 23andMe. Right off a fresh $115 million cash infusion, the Food and Drug Administration is giving the direct-to-consumer DNA company the green light to include health and carrier status, along with ancestry reports. This was not the scenario two years ago when the FDA put a moratorium on 23andMe’s ability to provide any health information associated with… Read More
-
23andMe Ceases Health-Focused Gene Testing, Still Offers Raw Genetic Data And Ancestry Reports
After the Food and Drug Administration ordered that 23andMe suspend use of its at-home gene testing kits, based on the government organization’s belief that it constitutes a medical device and thus requires further examination and testing before it can be provided for sale. 23andMe followed up to that bombshell with the news that it would be working with the FDA to try to resolve the… Read More
-
DNA Testing Startup 23andMe Hits A Snag As FDA Shuts Down Sales Of Home Testing Kit
The U.S. Food and Drug Administration has ordered 23andMe, the genomic startup co-founded by Anne Wojcicki, Linda Avey and Paul Cusenza in 2006, to stop selling its at-home DNA testing kits as of November 22. As Bloomberg reports, a letter from the FDA sent to the company made public today classifies the kit as a medical device and outlines that it required regulatory approval before being… Read More
Message Us